MedTrace Logo

Study on Retroplacental Hematomas in Finistère

NCT04168606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2020-09-11

No results posted yet for this study

Summary

Cases with placental abruption will be identified by interrogation of two databases of Brest University Hospital between January 2013 and December 2018. First trimester PAPPA and bhCG levels will be recorded. PlGF levels will be measured in women with an available first trimester serum sample. Histological findings in placentas, course of pregnancies, maternal and fetal characteristics will described and compared between cases with and without placental chronic inflammation.

Conditions

  • Placental Abruption
  • Placenta Diseases

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2019-09-23
Completion
2020-04-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168606 on ClinicalTrials.gov